Disease spotlight: LHON

Newsletters and Deep Dive digital magazine
There are now two vaccines to protect against chikungunya approved for use in the US, after Bavarian Nordic gets the green light for Vimkunya.
Rare disease treatment poses distinct challenges for physicians, patients, caregivers, and pharma companies.
In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Web editor Nicole Raleigh spoke with Veeva Systems’ president of Europe, Chris Moore, for a discursive dive into the life sciences
Developments in the oncology space in 2024 brought hope to both industry and patients.
With more cytokine-based drugs entering clinical trials and novel combination and masking technologies being used, there is a growing need for experts to discuss, understand, and build on t
7th Neuroimmunology Drug Development Summit | February 25-27 2025 | Boston, MA
Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox